Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 37
  1. Apr 07, 2026 · 07:03 · FRX

    Fennec’s steady stream of real‑world data builds a foundation for label expansion – but near‑term catalysts remain incremental.

    Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

    01
  2. Apr 07, 2026 · 07:01 · VIVI

    Brazilian patent bolsters TempraMed’s IP moat ahead of VIVI Box launch.

    TempraMed Announces Additional Granted Brazilian Patent for Newest VIVI Box Product

    02
  3. Apr 07, 2026 · 07:01 · TELY

    Delivering essential medication with no friction, no delays, and no barriers

    TelyRx Holdings Inc. to Commence Trading on the Toronto Stock Exchange Effective April 7, 2026

    03
  4. Apr 07, 2026 · 07:00 · BLCO

    N/A

    Bausch + Lomb Launches Preloaded enVista Envy(TM) Full Range of Vision Intraocular Lenses in Europe

    04
  5. Apr 07, 2026 · 03:05 · BNXT

    BioNxt secures unitary EU patent, advancing European commercialization of its sublingual cladribine ODF platform

    BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries

    05
  6. Apr 06, 2026 · 06:52 · INNO

    Innovating drug delivery for chronic pain solutions

    Innocan Pharma Announces Closing of Additional Debenture

    06
  7. Apr 04, 2026 · 20:26 · KETA

    Tripsitter Clinic to settle $292,311 shares with debt

    Tripsitter Clinic to settle $292,311 shares with debt

    07
  8. Apr 02, 2026 · 18:15 · BETR

    Betterlife issues 2.15M shares in debenture conversion

    Betterlife issues 2.15M shares in debenture conversion

    08
  9. Apr 02, 2026 · 18:11 · QNTM

    Quantum Biopharma wins market manipulation lawsuit

    Quantum Biopharma wins market manipulation lawsuit

    09
  10. Apr 02, 2026 · 17:43 · SHRX

    Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering

    Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering

    10
  11. Apr 02, 2026 · 16:39 · RVX

    Resverlogix receives MCTO from ASC

    Resverlogix receives MCTO from ASC

    11
  12. Apr 02, 2026 · 12:29 · WELL

    Well Health forms partnership with AliveCor

    Well Health forms partnership with AliveCor

    12
  13. Apr 02, 2026 · 09:43 · KETA

    Tripsitter Clinic completes shares-for-debt settlement

    Tripsitter Clinic completes shares-for-debt settlement

    13
  14. Apr 02, 2026 · 08:30 · QNTM

    Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

    Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

    14
← Newer Older →